In March, the FDA cleared Dexcom’s Stelo, making it the first glucose biosensor that doesn’t require a prescription. The small, wearable device, worn on the back of the upper arm, is designed for people with Type 2 diabetes or pre-diabetes who are not using insulin. The corresponding app offers readouts, showing when users’ glucose levels spike and ebb throughout the day. “When someone sees their own personal data, that’s empowering, because they can do something about it,” says COO Jake Leach. Indeed, the app helps teach users how to minimize glucose spikes, by, say, eating fiber first during meals or taking a walk straight after eating.
Buy Now: Glucose Biosensor on Stelo
More Must-Reads from TIME
- How Donald Trump Won
- The Best Inventions of 2024
- Why Sleep Is the Key to Living Longer
- Robert Zemeckis Just Wants to Move You
- How to Break 8 Toxic Communication Habits
- Nicola Coughlan Bet on Herself—And Won
- Why Vinegar Is So Good for You
- Meet TIME's Newest Class of Next Generation Leaders
Contact us at letters@time.com